Skip to main content

Good news as WHO unveils drug to tackle excessive bleeding at childbirth

The World Health Organisation (WHO) says a new drug – Carbetocin – has the potential to save thousands of women’s lives in childbirth annually.

WHO said Carbetocin now serves as a new competition – with improved benefits – to Oxytocin, a standby drug used to prevent potentially-fatal bleeding after childbirth.

WHO said excessive bleeding after childbirth still kills around 70,000 mothers a year and currently, Oxytocin is the first-choice medication, but it must be kept cold, unlike the new drug, Carbetocin.

The study, partly led, among others, by WHO and published on Wednesday, suggested that the new drug which could be stored at normal temperatures, could save the lives of thousands in low- and lower-middle-income countries.

“This is a truly encouraging new development that can revolutionise our ability to keep mothers and babies alive,” said WHO Director-General Tedros Adhanom Ghebreyesus.

WHO said since Oxytocin must be stored and transported at a cool two to eight degrees Celsius – a difficult task in many countries – numerous women lack access to the medicine.

The global health agency said even if women could obtain Oxytocin, heat exposure might render the drug less effective.

The study, published in the New England Journal of Medicine, has shown the heat-stable Carbetocin is not only as safe and effective as Oxytocin but even without refrigeration – when stored at below 30 degrees Celsius and 75 percent relative humidity – it retains its efficacy for at least three years.

In the largest clinical trial of its kind, close to 30,000 women who gave birth vaginally were studied in Nigeria, Argentina, Egypt, India, Kenya, Singapore, South Africa, Thailand, Uganda and the United Kingdom.

Immediately after childbirth, each woman was randomly injected with a single dose of either heat-stable Carbetocin or Oxytocin – revealing that both were equally effective at preventing excessive bleeding.

Metin Gülmezoglu of WHO’s Department of Reproductive Health and Research described the report of Carbetocin as “very good news” for millions of women.

“The development of a drug to prevent postpartum haemorrhage that continues to remain effective in hot and humid conditions is very good news for the millions of women who give birth in parts of the world without access to reliable refrigeration,” Gülmezoglu said.

While Carbetocin has not yet been cleared for use beyond clinical trials, the next steps begin with a regulatory review, countries’ approval and then consideration by WHO’s Guideline Development Group.

However, WHO said that following the positive trial results, it would be working to advance affordable access to the potentially lifesaving drug in countries with a high maternal death rate.

Comments

Post a Comment

Popular posts from this blog

Kenyan Law Court dismisses case of man seeking compensation after his wife eloped with another man from hospital

  A lawsuit filed by a man seeking to be compensated by St Mary's Mission Hospital in Kenya for allowing his wife to leave the hospital with another man after giving birth, has been struck out by a law court.    The appellant had sued the St. Mary's Mission hospital at Kakamega law courts in 2020 seeking general damages from the facility on grounds that the hospital had discharged his wife and allowed her to leave with another man. After delivering and at the time of discharge, the wife of the appellant claimed he was the baby's father.   The court of appeal judges Patrick Kiage, Mumbi Ngugi and Francis Tuiyott sitting at the Kisumu Court of Appeal, empathized with the man, but disagreed that he (the appellant) be compensated by the hospital for not detaining his wife.  They upheld the lower court's judgement which added that there's no remedy that lies in the law for such grievances.   Kiage said;   "I agree that if a man takes the woman he loves to t...
Post a Comment
Read more

CJN Tanko unveils panel to hear Atiku’s appeal against Buhari

The Chief Justice of Nigeria, Ibrahim Tanko Mohammed is presiding over the 7-man panel that will hear the appeals filed by the People’s Democratic Party (PDP) and its presidential candidate, Atiku Abubakar, challenging the victory of President Muhammadu Buhari at the February 23 poll. Other members of the panel are Bode Rhodes-Vivour, Amiru Sanusi, Uwani Abaji, Ejembi Eko, John Inyang Okoro and Olukayode Ariwoola. Atiku and his party are challenging the September 11 judgment of the Justice Mohammed Garba-led Presidential Election Petitions Tribunal which affirmed President Buhari’s victory at the polls. The appeals hearing has generated some controversies especially due to the silence of the Supreme Court on the justices that would constitute the panel, with the Coalition of United Progressives Party (CUPP) demanding the use of seniority in selecting them. A senior member of Atiku’s legal team, Chief Chris Uche (SAN), told reporters that they considered it strange that as at ...
Post a Comment
Read more

FRSC reinforces directive on use of google maps while driving

The Federal Road Safety Corps (FRSC) has clarified its position on the use of Google Maps, The FCT Sector Commander of the Federal Road Safety Corps (FRSC), Ayuba Gora was quoted saying that driving with the aid of Google map using mobile phones is a serious traffic offence. Gora said this at the inauguration of the 2019 Ember Months Campaign by Lugbe Unit Command of the FRSC in Abuja yesterday. But, FRSC Spokesman Bisi Kazeem making reference to Gora’s comments said the Sector Commander was quoted out of context and his statement outrightly misrepresented. Kazeem said the FRSC as a technology-driven organisation is not and has never stood against the use of Google Maps by Motorists. The statement read: “To state the obvious, we have always enlightened the public on the position of the law on the use of phone while driving. “The statement he made during the flag off buttresses the position of the Corps, which is that any driver who intends to deploy the use of Google Map...
Post a Comment
Read more